Trials / Terminated
TerminatedNCT03166618
Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Correction of Temple Hollowing
A Multicenter, Single-Blind, Randomized, Parallel-Group, Controlled Study of the Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Correction of Temple Hollowing
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety and effectiveness of JUVÉDERM VOLUMA XC injectable gel in adult participants seeking correction of temple hollowing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Juvéderm® VOLUMA XC | Juvéderm® VOLUMA XC hyaluronic acid injectable gel |
Timeline
- Start date
- 2017-04-24
- Primary completion
- 2017-07-21
- Completion
- 2017-07-21
- First posted
- 2017-05-25
- Last updated
- 2018-10-18
- Results posted
- 2018-10-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03166618. Inclusion in this directory is not an endorsement.